In January 2025, MSD secured approval for Gardasil for men aged 9 to 26, and on April 14, 2025, the Chinese regulator approved the more advanced Gardasil 9 shot for men aged 16 to 26. MSD CEO ...

Nearly half of the respondents believe that HPV is more common in women and only linked to cervical cancer. The virus is actually more common in men, and is linked to neck, tongue, tonsil ...

On an earnings call in February, he answered question after question about plunging demand for his company’s vaccine against cancer-causing HPV in China, which previously powered Merck’s growth.

The United States has seen progress in reducing certain cancer risks, as overall smoking rates remain on a decline.

United States-based global pharmaceutical company MSD said on Monday that China's National Medical Products Administration has approved the use of multiple new indications of Gardasil®9, its ...

A 2023 systematic review indicates that globally, almost 1 in 3 men over the age of 15 have an infection with at least one genital HPV type. The review also suggests that 1 in 5 have an infection ...

An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.